Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on VRTX. Vertex Pharmaceuticals Incorporated's share was trading at $454.08 as of March 20th. VRTX's trailing and forward P/E were 29.63 and 23.81 respectively according to Yahoo Finance. Is VRTX a good stock to buy? robina-weermeijer--szKjHyPq28-unsplash Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. VRTX has attracted bullish investor attention following positive developments across its pipeline and strong financial positioning. The company's outlook is underpinned by the Phase 3 interim success of povetacicept in IgA nephropathy, which demonstrated a 49.8% reduction in proteinuria, de-risking the asset and fueling a 6.58% stock rally on March 9, accompanied by analyst upgrades. Read More: 15 AI Stocks That Are Quietly Making Investors Rich Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential Vertex plans a rolling
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- How The Vertex Pharmaceuticals (VRTX) Story Is Shifting Toward Nephrology And Beyond Cystic Fibrosis [Yahoo! Finance]Yahoo! Finance
- How Vertex's IgA Nephropathy Data and Accelerated FDA Pathway At Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
- My Top 3 Drug Stocks for March 2026 [Yahoo! Finance]Yahoo! Finance
- Assessing Vertex Pharmaceuticals (VRTX) Valuation After Positive RAINIER Trial Update And Accelerated IgAN Filing [Yahoo! Finance]Yahoo! Finance
- Block upgraded, Starbucks downgraded: Wall Street's top analyst calls [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 3/17/26 - Form 4
- 3/13/26 - Form 4
- 3/13/26 - Form 144
- VRTX's page on the SEC website